Alexandra Schlein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandra Schlein has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Elin Lundström
Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, SE-75185, Sweden
1 shared publication - Elisabeth Hedlund
Department of Surgical Sciences, Radiology, Uppsala University, 751 85 Uppsala, Sweden
1 shared publication - Eric C. Ehman
Department of Radiology, Mayo Clinic, Rochester, USA
1 shared publication - Karin Stålberg
Department of Women’s and Children’s Health, Uppsala University, SE-751 85 Uppsala, Sweden
1 shared publication - Negaur Iranpour
Department of Radiology, Stanford University, Palo Alto, CA 94305, USA
1 shared publication - Rebecca Rakow-Penner
Breast Imaging Division, Department of Radiology, UC San Diego Health, Koman Family Outpatient Pavilion, 9400 Campus Point Dr, La Jolla, CA 92037
1 shared publication
Latest Publications
- Open Access
Application of PET/MRI in Gynecologic Malignancies
The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.
Open AccessApplication of PET/MRI in Gynecologic Malignancies
The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.